MedTrace Logo

Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy

NCT04407832 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-05-29

No results posted yet for this study

Summary

The investigators used two different doses of esomeprazole (40 mg IV q.d. and 40 mg IV q6h for three days followed by esomeprazole 40 mg q.d. orally in two groups) after successful endoscopic therapy with heat probe therapy or hemoclip placement.

The goal of this study is to assess the outcomes of two different regimens of low vs. high dose of intravenous esomeprazole after endoscopic therapy in patients with peptic ulcer bleeding.

Conditions

  • Peptic Ulcer Bleeding

Interventions

DEVICE

heat probe or hemoclip

for hemostasis

DEVICE

heat probe or hemoclip

for hemostasis

Sponsors & Collaborators

  • Taipei Medical University Hospital

    collaborator OTHER

  • Dalin Tzu Chi General Hospital

    collaborator OTHER

  • Changhua Christian Hospital

    lead OTHER

Principal Investigators

  • Hwai-jeng Lin, M.D. · Taipei Medical University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-07-31
Completion
2013-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407832 on ClinicalTrials.gov